[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer

NCT01608009 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasm

Interventions

DRUG: Pazopanib and paclitaxel

Sponsor

Imperial College London

Collaborators

[object Object]